0001161697-22-000547.txt : 20221115
0001161697-22-000547.hdr.sgml : 20221115
20221115170021
ACCESSION NUMBER: 0001161697-22-000547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221111
FILED AS OF DATE: 20221115
DATE AS OF CHANGE: 20221115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Del Carmen Jeffrey
CENTRAL INDEX KEY: 0001816477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 221391908
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 11-11-2022
X0306
4
2022-11-11
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001816477
Del Carmen Jeffrey
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Commercial Officer
Common stock, par value $0.001 per share
2022-11-11
4
M
0
120000
2.86
A
120000
D
Common stock, par value $0.001 per share
2022-11-11
4
S
0
120000
16.228
D
0
D
Common stock, par value $0.001 per share
2022-11-11
4
M
0
19017
2.24
A
19017
D
Common stock, par value $0.001 per share
2022-11-11
4
S
0
19017
15.461
D
0
D
Options to purchase common stock
2.86
2022-11-11
4
M
0
120000
0
D
2019-08-06
Common Stock
120000
627000
D
Options to purchase common stock
2.24
2022-11-11
4
M
0
19017
0
D
2019-12-19
Common Stock
19017
607983
D
Shares were sold for personal reasons and does not relate to any disagreements with the Company. Mr. Del Carmen remains an officer of the Company.
Shares were sold in various lots from $15.87 to $16.44 per share. The price listed represents a weighted average price for the shares sold.
Shares were sold in various lots from $15.25 to $15.78 per share. The price listed represents a weighted average price for the shares sold.
Options vested in four annual tranches beginning on August 6, 2019.
Options vested in three annual tranches beginning on December 19, 2019.
/s/ Jeffrey Del Carmen
2022-11-15